Living Cell Technologies Statistics
Want to see AU:1AI full AI Analyst Report?
Living Cell Technologies (1AI) Stock Statistics & Valuation Metrics
Total Valuation
Living Cell Technologies has a market cap or net worth of AUD 16.22M. The enterprise value is AUD 14.24M.
- Market Cap
- AUD 16.22M
- Enterprise Value
- AUD 14.24M
Share Statistics
Living Cell Technologies has 2,027,571,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,027,571,000
- Owned by Insiders
- 1.28%
- Owned by Institutions
- ―
Financial Efficiency
Living Cell Technologies’s return on equity (ROE) is -0.64 and return on invested capital (ROIC) is -64.56%.
- Return on Equity (ROE)
- -0.64
- Return on Assets (ROA)
- -0.61
- Return on Invested Capital (ROIC)
- -64.56%
- Return on Capital Employed (ROCE)
- -0.74
- Revenue Per Employee
- 0
- Profits Per Employee
- -56.47K
- Employee Count
- 48
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Living Cell Technologies is -5.14. Living Cell Technologies’s PEG ratio is 0.06.
- PE Ratio
- -5.14
- PS Ratio
- 0.00
- PB Ratio
- 3.84
- Price to FCF
- -6.26
- Price to Operating Cash Flow
- -5.62
- PEG Ratio
- 0.06
Income Statement
In the last 12 months, Living Cell Technologies had revenue of 0 and earned -2.71M in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -3.14M
- Pretax Income
- -3.10M
- Net Income
- -2.71M
- EBITDA
- -3.14M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -2.91M and capital expenditures -3, giving a free cash flow of -2.91M billion.
- Operating Cash Flow
- -2.91M
- Free Cash Flow
- -2.91M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Living Cell Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -17.96%
- Earnings Yield
- -27.96%
Stock Price Statistics
- Beta
- 0.09
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 42.07
- Average Volume (3m)
- 646.41K
Important Dates
Living Cell Technologies upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Living Cell Technologies as a current ratio of 25.11, with Debt / Equity ratio of 0.00%
- Current Ratio
- 25.11
- Quick Ratio
- 24.09
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.01
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Living Cell Technologies has paid -384.47K in taxes.
- Income Tax
- -384.47K
- Effective Tax Rate
- 0.12
Enterprise Valuation
Living Cell Technologies EV to EBITDA ratio is -4.15, with an EV/FCF ratio of -4.47.
- EV to Sales
- 0.00
- EV to EBITDA
- -4.15
- EV to Free Cash Flow
- -4.47
- EV to Operating Cash Flow
- -4.47
Balance Sheet
Living Cell Technologies has AUD 3.94M in cash and marketable securities with AUD 0.00 in debt, giving a net cash position of AUD 3.94M billion.
- Cash & Marketable Securities
- AUD 3.94M
- Total Debt
- AUD 0.00
- Net Cash
- AUD 3.94M
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Living Cell Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -200.00%
Scores
- Smart Score
- 2
- AI Score
- 40
